The Current Ratio as of December 2024 (TTM) for AbCellera Biologics Inc. (ABCL) is 9.34

According to AbCellera Biologics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.34. This represents a change of 5.54% compared to the average of 8.85 of the last 4 quarters.

AbCellera Biologics Inc. (ABCL) Historical Current Ratio (quarterly & annually)

How has ABCL Current Ratio performed in the past?

The mean historical Current Ratio of AbCellera Biologics Inc. over the last ten years is 5.07. The current 9.34 Current Ratio has changed 18.30% with respect to the historical average. Over the past ten years (40 quarters), ABCL's Current Ratio was at its highest in in the September 2021 quarter at 16.22. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

AbCellera Biologics Inc. (ABCL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of AbCellera Biologics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AbCellera Biologics Inc. (ABCL) Average Current Ratio

How has ABCL Current Ratio performed in the past?

The current Current Ratio of AbCellera Biologics Inc. (ABCL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

AbCellera Biologics Inc. (ABCL) Current Ratio vs. Peers

How is ABCL’s Current Ratio compared to its peers?

AbCellera Biologics Inc.’s Current Ratio is less than CohBar, Inc. (15.69), greater than Hepion Pharmaceuticals, Inc. (1.30), greater than Rain Therapeutics Inc. (5.58), greater than Krystal Biotech, Inc. (7.97), less than AVROBIO, Inc. (26.17), greater than CureVac N.V. (6.20), greater than Reata Pharmaceuticals, Inc. (6.75), greater than Vir Biotechnology, Inc. (8.94), greater than Propanc Biopharma, Inc. (0.01), greater than PTC Therapeutics, Inc. (2.10), greater than Sarepta Therapeutics, Inc. (3.84), greater than Iovance Biotherapeutics, Inc. (4.22), greater than Madrigal Pharmaceuticals, Inc. (5.98),

Build a custom stock screener for AbCellera Biologics Inc. (ABCL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbCellera Biologics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AbCellera Biologics Inc. (ABCL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AbCellera Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.